ストックスクリーナーアプリを入手
94.08
1.86%
+1.72
アフターアワーズ：
94.08
Amedisys Inc. (AMED) 最新ニュース
Amedisys (AMED) Q1 Earnings Surpass Estimates, Margins Rise
Zacks Investment Research
Compared to Estimates, Amedisys (AMED) Q1 Earnings: A Look at Key Metrics
Zacks Investment Research
Amedisys (AMED) Q1 Earnings and Revenues Surpass Estimates
Zacks Investment Research
Amedisys Reports First Quarter 2024 Financial Results
GlobeNewswire Inc.
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Zacks Investment Research
Amedisys (AMED) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Zacks Investment Research
Here's Why Amedisys (AMED) is a Strong Value Stock
Zacks Investment Research
Should You Buy HCA Healthcare (HCA) Ahead of Q1 Earnings?
Zacks Investment Research
Quest Diagnostics (DGX) Beats Q1 Earnings and Revenue Estimates
Zacks Investment Research
Why Amedisys (AMED) is a Top Value Stock for the Long-Term
Zacks Investment Research
Why Is Amedisys (AMED) Down 2.5% Since Last Earnings Report?
Zacks Investment Research
How Amedisys (AMED) Stock Stands Out in a Strong Industry
Zacks Investment Research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Zacks Investment Research
Amedisys' (AMED) Q4 Earnings Miss Estimates, Margins Up
Zacks Investment Research
AMED vs. USPH: Which Stock Is the Better Value Option?
Zacks Investment Research
Amedisys (AMED) Reports Q4 Earnings: What Key Metrics Have to Say
Zacks Investment Research
Amedisys (AMED) Q4 Earnings Lag Estimates
Zacks Investment Research
Amedisys Reports Fourth Quarter and Year-End 2023 Financial Results
GlobeNewswire Inc.
Higher Visits to Soften Cost Blow for Teladoc (TDOC) Q4 Earnings
Zacks Investment Research
Can Low Patient Days Affect Community Health (CYH) Q4 Earnings?
Zacks Investment Research
Centene (CNC) to Provide Better Health Equity in North Carolina
Zacks Investment Research
Amedisys (AMED) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Zacks Investment Research
Amedisys Offers Molecular Testing for Rapid and Accurate Infection Diagnosis
GlobeNewswire Inc.
Philips (PHG) Q4 Earnings Beat Estimates, Revenues Fall Y/Y
Zacks Investment Research
Chemed (CHE) Up 4.8% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
Amedisys (AMED) Up 2.6% Since Last Earnings Report: Can It Continue?
Zacks Investment Research
0.33%
大文字化:
|
ボリューム (24 時間):